{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:23Z","timestamp":1790613803071,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein Cell"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s13238-018-0521-z","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T12:09:03Z","timestamp":1521029343000},"page":"178-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy"],"prefix":"10.1093","volume":"10","author":[{"given":"Lin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihe","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"issue":"22","key":"521_CR1","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","volume":"96","author":"V Agnello","year":"1999","unstructured":"Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96(22):12766\u201312771","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"521_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1021\/jm00156a028","volume":"29","author":"JJ Baldwin","year":"1986","unstructured":"Baldwin JJ, Christy ME, Denny GH, Habecker CN, Freedman MB, Lyle PA et al (1986) Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2. J Med Chem 29(6):1065\u20131080 (Epub 1 June 1986)","journal-title":"J Med Chem"},{"key":"521_CR3","doi-asserted-by":"publisher","unstructured":"Bang I, Choi HJ (2015) Structural features of beta2 adrenergic receptor: crystal structures and beyond. Mol Cells 38(2):105\u2013111. https:\/\/doi.org\/10.14348\/molcells.2015.2301 (Epub 30 Dec 2014)","DOI":"10.14348\/molcells.2015.2301"},{"key":"521_CR4","doi-asserted-by":"crossref","unstructured":"Barnes NM, Sharp T 91999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083\u20131152 (Epub 16 Aug 1999)","DOI":"10.1016\/S0028-3908(99)00010-6"},{"issue":"5","key":"521_CR5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0026-895X(25)10196-X","volume":"45","author":"KA Berg","year":"1994","unstructured":"Berg KA, Clarke WP, Chen Y, Ebersole BJ, McKay RD, Maayani S (1994) 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium\/calmodulin-dependent mechanisms. Mol Pharmacol 45(5):826\u2013836 (Epub 1 May 1994)","journal-title":"Mol Pharmacol"},{"key":"521_CR6","doi-asserted-by":"publisher","unstructured":"Brattelid T, Qvigstad E, Lynham JA, Molenaar P, Aass H, Geiran O et al I(2004) Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn Schmiedebergs Arch Pharmacol. 370(3):157\u2013166. https:\/\/doi.org\/10.1007\/s00210-004-0963-0 (Epub 15 Sep 2004).","DOI":"10.1007\/s00210-004-0963-0"},{"key":"521_CR7","doi-asserted-by":"publisher","unstructured":"Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X et al (2014) Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res 24(9):1050\u20131066. https:\/\/doi.org\/10.1038\/cr.2014.116 (Epub 27 Aug 2014)","DOI":"10.1038\/cr.2014.116"},{"key":"521_CR8","unstructured":"Communication FDS (2016) FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm522932.htm"},{"key":"521_CR9","doi-asserted-by":"publisher","unstructured":"Corbett DF, Heightman TD, Moss SF, Bromidge SM, Coggon SA, Longley MJ et al (2005) Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry. Bioorg Med Chem Lett 15(18):4014\u20134018. https:\/\/doi.org\/10.1016\/j.bmcl.2005.06.024 (Epub 9 July 2005)","DOI":"10.1016\/j.bmcl.2005.06.024"},{"key":"521_CR10","doi-asserted-by":"publisher","unstructured":"Cui HK, Qing J, Guo Y, Wang YJ, Cui LJ, He TH et al (2013) Stapled peptide-based membrane fusion inhibitors of hepatitis C virus. Bioorg Med Chem 21(12):3547\u20133554. https:\/\/doi.org\/10.1016\/j.bmc.2013.02.011 (Epub 16 March 2013)","DOI":"10.1016\/j.bmc.2013.02.011"},{"key":"521_CR11","doi-asserted-by":"publisher","unstructured":"De Monte A, Courjon J, Anty R, Cua E, Naqvi A, Mondain V et al (2016) Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge. J Clin Virol Off Publ Pan Am Soc Clin Virol 78:27\u201330. https:\/\/doi.org\/10.1016\/j.jcv.2016.02.026 (Epub 12 March 2016).","DOI":"10.1016\/j.jcv.2016.02.026"},{"issue":"5","key":"521_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1474-8673.1995.tb00403.x","volume":"15","author":"SA Doggrell","year":"1995","unstructured":"Doggrell SA (1995) Increase in affinity and loss of 5-hydroxytryptamine2A-receptor reserve for 5-hydroxytryptamine on the aorta of spontaneously hypertensive rats. J Auton Pharmacol 15(5):371\u2013377 (Epub 1 Jan 1995)","journal-title":"J Auton Pharmacol"},{"issue":"7137","key":"521_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B et al (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801\u2013805","journal-title":"Nature"},{"key":"521_CR14","doi-asserted-by":"publisher","unstructured":"Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamaki A (2001) Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors. J Biol Chem 276(33):31279\u201331284. https:\/\/doi.org\/10.1074\/jbc.m104167200 (Epub 8 June 2001)","DOI":"10.1074\/jbc.m104167200"},{"issue":"2","key":"521_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7150\/ijms.6.93","volume":"6","author":"AD French","year":"2009","unstructured":"French AD, Fiori JL, Camilli TC, Leotlela PD, O\u2019Connell MP, Frank BP et al (2009) PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci 6(2):93\u2013101 (Epub 24 March 2009)","journal-title":"Int J Med Sci"},{"issue":"8","key":"521_CR16","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1073\/pnas.0831128100","volume":"100","author":"JP Gardner","year":"2003","unstructured":"Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T et al (2003) L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 100(8):4498\u20134503","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"521_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jmv.10196","volume":"68","author":"R Germi","year":"2002","unstructured":"Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW et al (2002) Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol 68(2):206\u2013215","journal-title":"J Med Virol"},{"issue":"5","key":"521_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.celrep.2015.06.063","volume":"12","author":"G Gerold","year":"2015","unstructured":"Gerold G, Meissner F, Bruening J, Welsch K, Perin PM, Baumert TF et al (2015) Quantitative proteomics identifies serum response factor binding protein 1 as a host factor for hepatitis C virus entry. Cell Rep 12(5):864\u2013878","journal-title":"Cell Rep"},{"key":"521_CR19","doi-asserted-by":"publisher","unstructured":"Gondar V, Molina-Jimenez F, Hishiki T, Garcia-Buey L, Koutsoudakis G, Shimotohno K et al (2015) Apolipoprotein E, but not apolipoprotein B, is essential for efficient cell-to-cell transmission of hepatitis C virus. J Virol 89(19):9962\u20139973. https:\/\/doi.org\/10.1128\/jvi.00577-15 (Epub 24 July 2015)","DOI":"10.1128\/jvi.00577-15"},{"key":"521_CR20","doi-asserted-by":"publisher","unstructured":"Han Q, Xu C, Wu C, Zhu W, Yang R, Chen X (2009) Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Res 145(1):63\u201373. https:\/\/doi.org\/10.1016\/j.virusres.2009.06.005 (Epub 23 June 2009)","DOI":"10.1016\/j.virusres.2009.06.005"},{"issue":"1","key":"521_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/aac.01008-06","volume":"51","author":"W Hao","year":"2007","unstructured":"Hao W, Herlihy KJ, Zhang NJ, Fuhrman SA, Doan C, Patick AK et al (2007) Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening. Antimicrob Agents Chemother 51(1):95\u2013102. https:\/\/doi.org\/10.1128\/aac.01008-06","journal-title":"Antimicrob Agents Chemother"},{"key":"521_CR22","doi-asserted-by":"publisher","unstructured":"Harris HJ, Davis C, Mullins JG, Hu K, Goodall M, Farquhar MJ et al (2010) Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 285(27):21092\u201321102. https:\/\/doi.org\/10.1074\/jbc.m110.104836 (Epub 9 April 2010)","DOI":"10.1074\/jbc.m110.104836"},{"key":"521_CR23","doi-asserted-by":"publisher","unstructured":"He S, Lin B, Chu V, Hu Z, Hu X, Xiao J et al (2015) Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection. Sci Transl Med 7(282):282ra49. https:\/\/doi.org\/10.1126\/scitranslmed.3010286 (Epub 10 April 2015).","DOI":"10.1126\/scitranslmed.3010286"},{"key":"521_CR24","doi-asserted-by":"crossref","unstructured":"Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71(4):533\u2013554 (Epub 13 March 2002)","DOI":"10.1016\/S0091-3057(01)00746-8"},{"issue":"10","key":"521_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrmicro3098","volume":"11","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach BD, Rice CM (2013) The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11(10):688\u2013700","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"521_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.25665","volume":"56","author":"S Liu","year":"2012","unstructured":"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T (2012) Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Hepatology 56(2):484\u2013491","journal-title":"Hepatology"},{"issue":"5424","key":"521_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285(5424):110\u2013113","journal-title":"Science"},{"issue":"22","key":"521_CR28","doi-asserted-by":"publisher","first-page":"20358","DOI":"10.1074\/jbc.M301284200","volume":"278","author":"PY Lozach","year":"2003","unstructured":"Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A et al (2003) DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278(22):20358\u201320366","journal-title":"J Biol Chem"},{"issue":"5","key":"521_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L et al (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17(5):589\u2013595","journal-title":"Nat Med"},{"key":"521_CR30","doi-asserted-by":"publisher","unstructured":"Mahe C, Loetscher E, Feuerbach D, Muller W, Seiler MP, Schoeffter P (2004) Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur J Pharmacol 495(2\u20133):97\u2013102. https:\/\/doi.org\/10.1016\/j.ejphar.2004.05.033 (Epub 14 July 2004)","DOI":"10.1016\/j.ejphar.2004.05.033"},{"issue":"26","key":"521_CR31","doi-asserted-by":"publisher","first-page":"10777","DOI":"10.1073\/pnas.1301764110","volume":"110","author":"DN Martin","year":"2013","unstructured":"Martin DN, Uprichard SL (2013) Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci USA 110(26):10777\u201310782","journal-title":"Proc Natl Acad Sci USA"},{"key":"521_CR32","doi-asserted-by":"publisher","unstructured":"Ozaras R, Yemisen M, Balkan II (2013) Current and future therapies for hepatitis C virus infection. N Engl J Med 369(7):679. https:\/\/doi.org\/10.1056\/nejmc1307589#sa1 (Epub 16 Aug 2013)","DOI":"10.1056\/nejmc1307589#sa1"},{"issue":"5390","key":"521_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R et al (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938\u2013941","journal-title":"Science"},{"issue":"7231","key":"521_CR34","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","volume":"457","author":"A Ploss","year":"2009","unstructured":"Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP et al (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882\u2013886","journal-title":"Nature"},{"key":"521_CR35","doi-asserted-by":"publisher","unstructured":"Popoli M (2009) Agomelatine: innovative pharmacological approach in depression. CNS Drugs 23(Suppl 2):27\u201334 https:\/\/doi.org\/10.2165\/11318640-000000000-00000 (Epub 4 Sep 2009)","DOI":"10.2165\/11318640-000000000-00000"},{"issue":"4\u20135","key":"521_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","volume":"14","author":"MN Prichard","year":"1990","unstructured":"Prichard MN, Shipman C Jr (1990) A three-dimensional model to analyze drug\u2013drug interactions. Antiviral Res 14(4\u20135):181\u2013205","journal-title":"Antiviral Res"},{"key":"521_CR37","doi-asserted-by":"publisher","unstructured":"Qing J, Luo R, Wang Y, Nong J, Wu M, Shao Y et al (2016) Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus. Antiviral Res 126:43\u201354. https:\/\/doi.org\/10.1016\/j.antiviral.2015.12.010 (Epub 3 Jan 2016)","DOI":"10.1016\/j.antiviral.2015.12.010"},{"key":"521_CR38","doi-asserted-by":"publisher","unstructured":"Raote I, Bhattacharyya S, Panicker MM (2013) Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation. Mol Pharmacol 83(1):42\u201350. https:\/\/doi.org\/10.1124\/mol.112.078626 (Epub 5 Oct 2012)","DOI":"10.1124\/mol.112.078626"},{"issue":"2\u20133","key":"521_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","volume":"92","author":"JR Raymond","year":"2001","unstructured":"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW et al (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92(2\u20133):179\u2013212 (Epub 28 March 2002)","journal-title":"Pharmacol Ther"},{"issue":"2","key":"521_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.2581","volume":"18","author":"B Sainz Jr","year":"2012","unstructured":"Sainz B Jr, Barretto N, Martin DN, Hiraga N, Imamura M, Hussain S et al (2012) Identification of the Niemann\u2013Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18(2):281\u2013285","journal-title":"Nat Med"},{"issue":"19","key":"521_CR41","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G et al (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017\u20135025","journal-title":"EMBO J"},{"key":"521_CR42","doi-asserted-by":"publisher","unstructured":"Shukla P, Faulk KN, Emerson SU (2010) The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles. J Med Virol 82(5):783\u2013790. https:\/\/doi.org\/10.1002\/jmv.21660 (Epub 26 March 2010)","DOI":"10.1002\/jmv.21660"},{"key":"521_CR43","doi-asserted-by":"publisher","unstructured":"Tamir H, Hsiung SC, Yu PY, Liu KP, Adlersberg M, Nunez EA et al (1992) Serotonergic signalling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin. Synapse (N Y, NY) 12(2):155\u2013168. https:\/\/doi.org\/10.1002\/syn.890120209 (Epub 1 Oct 1992)","DOI":"10.1002\/syn.890120209"},{"issue":"7","key":"521_CR44","first-page":"1001","volume":"26","author":"S Tsukagoshi","year":"1999","unstructured":"Tsukagoshi S (1999) Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist. Gan To Kagaku Ryoho 26(7):1001\u20131008 (Epub 9 July 1999)","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"521_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1073\/pnas.1506524113","volume":"113","author":"S Ujino","year":"2016","unstructured":"Ujino S, Nishitsuji H, Hishiki T, Sugiyama K, Takaku H, Shimotohno K (2016) Hepatitis C virus utilizes VLDLR as a novel entry pathway. Proc Natl Acad Sci USA 113(1):188\u2013193","journal-title":"Proc Natl Acad Sci USA"},{"key":"521_CR46","doi-asserted-by":"publisher","unstructured":"Upton N, Chuang TT, Hunter AJ, Virley DJ (2008) 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer\u2019s disease. Neurotherapeutics 5(3):458\u2013469. https:\/\/doi.org\/10.1016\/j.nurt.2008.05.008 (Epub 16 July 2008)","DOI":"10.1016\/j.nurt.2008.05.008"},{"key":"521_CR47","doi-asserted-by":"publisher","unstructured":"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A et al (2010) Rigid analogues of the alpha2-adrenergic blocker atipamezole: small changes, big consequences. J Med Chem 53(19):6986\u20136995 https:\/\/doi.org\/10.1021\/jm1006269 (Epub 3 Sep 2010)","DOI":"10.1021\/jm1006269"},{"issue":"4","key":"521_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00005344-198804000-00006","volume":"11","author":"AH Meiracker van den","year":"1988","unstructured":"van den Meiracker AH, Man in \u2019t Veld AJ, Fischberg DJ, Molinoff PB, van Eck HJ, Boomsma F et al (1988) Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol 11(4):413\u2013423 (Epub 1 April 1988)","journal-title":"J Cardiovasc Pharmacol"},{"key":"521_CR49","doi-asserted-by":"publisher","unstructured":"Wang C, Ji D, Chen J, Shao Q, Li B, Liu J et al (2017) Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 15(1):132\u2013136. https:\/\/doi.org\/10.1016\/j.cgh.2016.06.023 (Epub 10 July 2016)","DOI":"10.1016\/j.cgh.2016.06.023"},{"issue":"9973","key":"521_CR50","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","volume":"385","author":"DP Webster","year":"2015","unstructured":"Webster DP, Klenerman P, Dusheiko GM (2015) Hepatitis C. Lancet 385(9973):1124\u20131135","journal-title":"Lancet"},{"issue":"19","key":"521_CR51","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/jo00881a011","volume":"41","author":"LM Weinstock","year":"1976","unstructured":"Weinstock LM, Mulvey DM, Tull R (1976) Synthesis of the beta-adrenergic blocking agent timolol from optically active precursors. J Org Chem 41(19):3121\u20133124 (Epub 17 Sep 1976)","journal-title":"J Org Chem"},{"issue":"3","key":"521_CR52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2165\/00003495-199345030-00008","volume":"45","author":"MI Wilde","year":"1993","unstructured":"Wilde MI, Fitton A, McTavish D (1993) Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 45(3):410\u2013429 (Epub 1 March 1993)","journal-title":"Drugs"},{"issue":"22","key":"521_CR53","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1128\/JVI.01307-06","volume":"80","author":"J Zhong","year":"2006","unstructured":"Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G et al (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80(22):11082\u201311093","journal-title":"J Virol"}],"container-title":["Protein &amp; Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13238-018-0521-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-018-0521-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-018-0521-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:00:58Z","timestamp":1751486458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/proteincell\/article\/10\/3\/178\/6759273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1007\/s13238-018-0521-z","relation":{},"ISSN":["1674-800X","1674-8018"],"issn-type":[{"value":"1674-800X","type":"print"},{"value":"1674-8018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"5 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}